Search Medical Condition
Please enter condition
Please choose location
 

Infectious Colitis Clinical Trials

A listing of Infectious Colitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (6) clinical trials

To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0 and 2.

Phase

Winthrop University Hospital’s Clinical Trials Center is seeking volunteers with moderately to severely active Ulcerative Colitis. The main purpose of this study is to see if an investigational medication is useful and safe for treating patients with moderately to severely active ulcerative colitis. Eligible participants will receive study-related medication and ...

Phase

A phase 3 research study of an oral investigational medication as induction and maintenance therapy for adults ages 18 to 75 with moderate to severe ulcerative colitis. Note, study participants may receive the investigational medication or placebo. For more information, please visit our study website at: www.TrueNorthStudy.com

Phase

Inflammatory bowel diseases, including ulcerative colitis, are chronic relapsing disorders characterized by destructive inflammation and epithelial injury in the gastrointestinal tract. This study will evaluate the efficacy of intravenous (IV) ustekinumab in inducing clinical remission in subjects with moderately to severely active ulcerative colitis.

Phase N/A

The purpose of the study is to assess the effect of Vedolizumab subcutaneously on clinical remission at Week 52 in subjects with moderately to severely active UC, who achieved a clinical response at Week 6, following the administration of Vedolizumab IV.

Phase

The purpose of the study is to determine the effect of Vedolizumab IV compared to adalimumab SC on achieving clinical remission in patients with Ulcerative Colitis, at Week 52.

Phase